Proof of Concept Study for 1 Lead Patch Technology

Stopped early · Not applicable

Conditions studied: Telemetry

In brief

This study is intended to assess the feasibility and usability of the 1 Lead Patch as a whole, on patients outside the hospital, in the out-patient setting.

Key facts

Study ID

NCT02533531

Run by

LifeWatch Services, Inc.

People needed

1

Starts

2014-04-16

Expected to finish

2016-06-09

Last updated by the study team

2018-04-06

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Adult male or female referred for 3 Lead ACT monitoring for between 7 and 14 days.
• Be recently prescribed a LifeWatch 3 Lead ACT monitor

You may not qualify if…

• under 21-years old
• pregnant or who may become become pregnant during the investigation period
• using internal or external defibrillators
• who are using pacemakers or implantable loop recorders
• showing skin damage on the chest, such as burns, irritation, infections, wounds, etc.
• meeting any contraindications for a patch biosensor

Where it is running

• Mt. Sinai Medical Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.